Marrone Bio Innovations (MBII) Aktie Kurs

Marrone Bio Innovations Kurs

NASDAQ·LUKKET
0
​
Markedet lukket

Omsætningen er vokset med 25,3 % om året de seneste 11 år til 44,31 Mio. USD. Marrone Bio Innovationss nettoavance ligger på -37,4 %, op fra -170,2 % for flere år siden.

Marrone Bio Innovations aktiekurs

Hent disse data via Eulerpool API

100.000 requests/md. gratis · intet kreditkort

Marrone Bio Innovations aktie og aktieanalyse

Marrone Bio Innovations Inc. er et amerikansk selskab, der har været aktivt inden for biologisk skadedyrsbekæmpelse siden 2006. Selskabet blev grundlagt af kemikeren Dr. Pamela Marrone og har hovedkvarter i Davis, Californien. Forretningsmodellen er baseret på udvikling af sikre og effektive produkter til biologisk skadedyrsbekæmpelse fremstillet af naturlige ingredienser. Formålet er at minimere landbrugets miljømæssige påvirkning. Virksomheden er opdelt i forskellige divisioner, herunder biologisk plantebeskyttelse, biologisk kvælstofbinding, biologisk ukrudtsbekæmpelse og andre produkter. Kendte produkter omfatter Regalia®, Venerate® og Majestene®. Marrone Bio Innovations har vundet betydning de seneste år og er nu en af de førende virksomheder inden for biologisk skadedyrsbekæmpelse. Selskabet samarbejder tæt med landmænd, forskningsinstitutioner og tilsynsmyndigheder for at udvikle og introducere nye produkter, hvor sikkerhed og miljøvenlighed altid prioriteres.

Hyppigt stillede spørgsmål om Marrone Bio Innovations-aktien

The business model of Marrone Bio Innovations Inc is focused on providing sustainable and environmentally friendly solutions for the agriculture and water treatment industries. Marrone Bio Innovations develops and manufactures bio-based products that protect crops from pests and diseases, improve plant health, and enhance water quality. Their products are derived from naturally occurring microorganisms, which provide effective and safe alternatives to traditional chemical-based pesticides. Marrone Bio Innovations' innovative and eco-friendly solutions aim to help farmers increase crop yields while minimizing environmental impacts.

Marrone Bio Innovations Inc is primarily active in the agriculture and biotechnology industries.

The main competitors of Marrone Bio Innovations Inc in the market include Syngenta AG, Bayer AG, BASF SE, and Corteva Agriscience.

Marrone Bio Innovations Inc is an innovative company that focuses on providing sustainable biological solutions for agriculture and water treatment. Founded in 2006, Marrone Bio Innovations has rapidly grown to become a global leader in the development and commercialization of environmentally friendly and effective biopesticides and plant health products. With a mission to improve the quality and quantity of global food and water supply, the company offers a wide range of natural products that help farmers protect their crops against pests, diseases, and weeds. Marrone Bio Innovations continues to revolutionize the agricultural industry with its cutting-edge technologies and commitment to sustainability.

Marrone Bio Innovations Inc has achieved several significant milestones. The company successfully launched numerous innovative and sustainable bio-based products, establishing a strong position in the agricultural industry. Marrone Bio Innovations Inc also expanded its global reach by establishing strategic partnerships and collaborations with key players in the market. Additionally, the company received various recognitions and awards for its contributions to sustainable agriculture and environmental stewardship. Marrone Bio Innovations Inc continues to drive advancements in biopesticides, biofertility products, and other bio-based solutions, aiming to revolutionize the way pest management and crop protection are approached in modern agriculture.

Marrone Bio Innovations Inc is primarily present in the United States, focusing on various regions within the country. With their headquarters in Davis, California, the company operates across different states, including key agricultural areas such as California's Central Valley and the Midwest. Marrone Bio Innovations Inc also has a presence in international markets, particularly in Europe, where they have established partnerships and distribution networks to expand their reach.

Marrone Bio Innovations Inc represents a commitment to sustainable and environmentally friendly solutions in the agricultural industry. The company focuses on developing and commercializing bio-based pest management and plant health products, aiming to improve crop yields while minimizing the use of synthetic chemicals. With a strong dedication to innovation, Marrone Bio Innovations Inc strives to provide effective and safe products that help farmers maintain healthy and profitable crops. The company's corporate philosophy revolves around sustainability, responsibility, and a dedication to creating a more sustainable and resilient agriculture system.

10 analytikere vurderer i øjeblikket Marrone Bio Innovations-aktien: 7 anbefaler køb, 3 hold og 0 salg.

Marrone Bio Innovations-aktien (MBII) er noteret på 1 børser, herunder: NASDAQ (MBII).

The company Marrone Bio Innovations Inc is a leading provider of biological solutions for agriculture and horticulture. The company specializes in the development and marketing of biological pesticides and fertilizers used in agriculture and horticulture. Marrone Bio Innovations' business model is based on the development and marketing of biological products that are safe, effective, and environmentally friendly. The company has divided its products into different categories to best meet the needs of its customers. The core areas of Marrone Bio Innovations are plant protection and fertilization. In the field of plant protection, the company offers a wide range of biological pesticides that combat harmful insects, fungi, and diseases that can affect crop yield and quality. Some of the most well-known products include Grandevo®, Regalia®, Venerate®, Majestene®, Stargus®, and Zequanox®. Marrone Bio Innovations also has a strong presence in the field of fertilization. The company offers biological fertilizers that enrich the soil naturally and support plant growth. Optimized nutrient supply is an important factor in increasing crop quality and yield. Some of the most well-known products include Haven®, Haven CX®, Haven SW®, Haven Pure®, Haven Topper®, and Stargus®. Another important area of Marrone Bio Innovations is the development of biological solutions for horticulture, including growth stimulants for use on lawns, biostimulants for use on ornamental plants, and biological pesticides for use in home gardens. Some of the most well-known products include Haven® for lawns and GardenShield® for ornamental plants. Marrone Bio Innovations has expanded its business model with a strong research and development department. The company continuously invests in the development of new biological products that meet the highest standards. It works closely with scientists, universities, and other experts. Overall, Marrone Bio Innovations has developed a business model based on the development and marketing of biological solutions for agriculture and horticulture. By dividing its products into different categories, the company is able to tailor its products to the needs of its customers. Marrone Bio Innovations focuses on quality and research, working closely with experts to meet the highest standards and offer innovative and environmentally friendly products to its customers.

Omsætningen kan for øjeblikket ikke beregnes for Marrone Bio Innovations.

Overskuddet kan for øjeblikket ikke beregnes for Marrone Bio Innovations.

P/E-forholdet kan ikke beregnes for Marrone Bio Innovations i øjeblikket.

P/S-forholdet kan ikke beregnes for Marrone Bio Innovations i øjeblikket.

AlleAktien-kvalitetsscore for Marrone Bio Innovations er 4/10.

ISIN for Marrone Bio Innovations er US57165B1061. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for Marrone Bio Innovations er A1W30B. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for Marrone Bio Innovations er MBII. Tickersymbolet bruges til at handle Marrone Bio Innovations-aktier på børsen.

Fair værdiTerminal
148.30 USD
Over-/underværdieringTerminal
Fair værdieret
Industri
Kemikalier
Antal aktier
Medarbeidere
Omsætning pr. medarbejder
305.586,21 USD
Omsætningsvækst Ø5 år
EBIT-vækst Ø5 år
Resultatvækst Ø5 år
Land
Valuta
USD
Børsintroduktion
2. aug. 2013
ISIN
US57165B1061
CUSIP
57165B106
SEDOL
BCFKQV1
Markedsværdi
52-ugers interval
AAQS
4 / 10
PEG-forhold
—
P/E-forhold
P/Ee 2022
—
P/S
P/Se
—
EV/EBIT
—
K/B-forhold
4,91
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-26,17 %
Sidst opdateret 11. nov. 2026, 17.55

Marrone Bio Innovations Ticker

NASDAQ · MBII

Marrone Bio Innovations FIGI

MBIIUSD:XB · BBG00JRXYM82MBIIUSD:XS · BBG00JRXYMR1MBIIGBP:XS · BBG00KDGG953

Alle fundamentale data om Marrone Bio Innovations i deep dive

Vores aktieanalyse af Marrone Bio Innovations-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Marrone Bio Innovations. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: